In addition, the teams of Drost (49) and Roper (50) used another gene-editing technique, CRISPR-Cas9, to mutate the oncogenes APC and TP53 in the organoid tissue, and elucidated that the invasive CRC arose from the position where edited organoid transplanted into mice. The gene discussed is APC; the disease is colorectal carcinoma.